Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025.

Revenue
+13.7%
EPS
+42.0%
Free cash flow
+120.9%
Total debt
−1.59%

Quarter to July 2026, against a year earlier

101.77 3.07 −2.93%
Market cap
$134.1B
P/E
25.6×
Fwd P/E
20.8×
Dividend yield
2.74%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
P/E ratio
20.93 21.65 28.61 24.45

+8 more quarters

P/S ratio
2.91 2.85 3.71 3.35
P/FCF ratio
17.82 19.13 24.35 22.34
P/Operating CF
60.95 40.34 48.01 125.71
P/B ratio
2.15 2.07 2.68 2.38
EV/Sales
3.43 3.37 4.27 3.94
EV/EBITDA
13.23 13.00 16.62 14.85
EV/FCF
20.97 22.58 27.99 26.33
Current Ratio
2.07 2.13 2.54 2.42
Net Debt/EBITDA
7.76 7.24 8.90 8.55
Debt/Equity
0.55 0.56 0.57 0.60
Earnings Yield
4.78% 4.62% 3.50% 4.09%
Free Cash Flow Yield
5.61% 5.23% 4.11% 4.48%
Free Cash Flow per Share
1.01 1.63 1.79 0.36
Book value per Share
39.73 39.06 38.36 38.11
Free Cash Flow
1,290.00 2,085.00 2,300.00 457.00
EV/EBIT
18.95 18.95 25.11 22.06
Other line items

Show all line items

Columns are period end dates